Participated · Series B · Jan 2026

Visitt offers a unified, AI-embedded property operations platform for commercial real estate owners and operators across office, industrial, data center, multifamily, and retail assets. The software merges traditionally siloed functions—including work orders, compliance, predictive maintenance, tenant communications, equipment tracking, security, amenities, and finance—into a single interface. Powered by millions of operational data points and constant feedback from on-site teams, the platform delivers 2–3× improvements in property efficiency and response times while eliminating repetitive tasks. In 2025 the company surpassed 150 customers and achieved more than 900 % growth in managed square footage. Current AI features include work-order intelligence, a certificate-of-insurance agent, and multilingual communication tools, with plans to add additional AI agents that reduce manual work and provide deeper predictive insights. The firm also intends to scale its customer-success organization and enhance its proprietary onboarding technology, aiming to save thousands of hours per portfolio annually.

Led · Seed · Jan 2026

Feminai is an Israeli health-tech startup building a wearable sensor patch that continuously monitors breast tissue density and blood-flow patterns, then analyzes the data with proprietary AI algorithms to detect early signs of breast cancer. The company’s first in-human clinical trial at Sheba Medical Center reported 96% sensitivity and a 98% negative predictive value, indicating strong diagnostic accuracy. Co-founded by physician-CEO Dr. Karny Ilan along with Gal Yanuka and Shani Klein, Feminai aims to replace or supplement clinic-based imaging with a more accessible, affordable, and user-friendly home solution. The recent seed funding equips the team to scale hiring, pursue regulatory clearances, and finalize go-to-market preparations. Feminai ultimately intends to bring its device to global markets as a subscription or device-plus-software service, targeting earlier detection and improved outcomes for women’s health. Prior to the seed round, no additional funding amounts were disclosed.

Participated · Series A · Jul 2025

C8 Health offers a unified best-practices implementation platform that gives clinicians instant, contextual access to vetted, site-specific knowledge based on schedule, role, and department. The product includes an AI assistant that answers natural-language questions from an institution's vetted knowledge base and connects users to a growing global network of hospital and clinical-society content. The platform integrates with hospital tools and EMRs and is accessible via mobile devices and desktops, supporting system-wide deployments beyond its initial Anesthesia vertical. C8 is already integrated at over 100 hospitals and achieves over 90% clinician adoption within six months of deployment. Financially, the company has raised $18 million to date and plans to use the new capital to grow its team to meet market demand. Customers cited in the article include Dartmouth Health and Metro Health, which have seen improved access to resources and high clinician satisfaction.

Led · Series A · Jul 2025

Seal Security is an application security provider that automatically curates and delivers production-ready patches to eliminate open source vulnerabilities across the software stack, from dependencies and operating systems to container base images. Its platform installs fixes without requiring version upgrades or complex migrations, enabling teams to keep current environments secure and protect future deployments. The company emphasizes a patching-first approach powered by LLMs to reduce vulnerability backlogs and accelerate remediation. Seal reports rapid customer growth, substantial ARR expansion, and has more than doubled headcount over the past year. It commits to a 72-hour CVE remediation SLA and targets AppSec, DevOps, DevSecOps, and IT teams in regulated environments. Seal says customers achieve remediation in hours or minutes and that the product helps maintain compliance with standards such as PCI DSS, FedRAMP, DORA, CRA, and NYDFS. The company plans to use the new funding to enhance go-to-market efforts and accelerate expansion of its core platform. Seal Security builds tooling that goes beyond vulnerability scanning by creating and applying patches to remediate issues in open-source packages. Its platform integrates with GitHub to enable these patches in customers' CI/CD pipelines and automates much of the workflow. The company generates patches itself and leverages a large language model to help identify the commits that introduced fixes, which the team says enables scalability. Seal was founded by Itamar Sher (CEO), Lev Pachmanov (CTO) and Alon Navon (CPO); the team joined forces in summer 2022 after prior roles at Unit 8200, Cymmetria, Curv and PayPal. The product aims to reduce alert noise for developers and shift enterprise focus from triage to remediation. Financially, Seal announced a $7.4 million seed round led by Vertex Ventures Israel, with participation from Crew Capital, PayPal Alumni Fund and Cyber Club London.

Participated · Series C · Mar 2025

Navina builds an AI-powered clinical intelligence platform (an AI copilot) that turns fragmented patient data into concise patient profiles and actionable insights at every clinical touchpoint. The product natively integrates into clinician workflows to support decision-making across the care continuum and reduce administrative burden. Navina serves over 10,000 healthcare professionals across 1,300 clinics and supports care for more than three million patients, with an 86% weekly active usage rate. The company has partnerships with agilon health, InnovaCare Health, Millennium Physician Group, and Privia Health, and was recognized Best in KLAS 2025 for Clinician Digital Workflow. Navina plans to accelerate development of its proprietary AI to become a unified source of patient data and to expand platform capabilities from proactive population health management to point-of-care intervention. Financially, the company has raised $100 million to date after completing a $55 million Series C. Navina develops an AI-powered assistant platform that structures and summarizes complex medical data for primary care physicians at the point of care. Its models were trained on a curated dataset of imaging notes, consult notes, hospital notes, procedures and labs and the software integrates with existing electronic health records to surface potential diagnoses and quality or risk gaps. The company emphasizes fitting into existing clinical workflows and aims to expand its product into home, virtual and urgent care settings. Navina says it is HIPAA-compliant, has completed a third-party privacy audit and is in the final stages of SOC2 certification. The platform is used by "thousands" of clinicians and supporting staff; Navina currently has 65 employees and expects to have about 75 by year end. The team was founded by Ronen Lavi and Shay Perera, who previously led the Israel Defense Forces' AI lab and used that experience to build Navina's assistant systems. Navina builds an AI-powered clinical platform for primary care that consolidates disorganized patient data into an intuitive "Patient Portrait" logical grid to help physicians assess complex cases quickly. Led by co-founder and CEO Ronen Lavi, the platform is medically informed and has demonstrated measurable clinical and economic impact for multi-specialty and primary care physician groups nationwide. Adopters have seen increases in HCC-RAF (Risk Adjustment Factor) scores, which the company says translates into revenue. Navina intends to use new funding to accelerate investment in its AI technology and to expand within physician groups and the enterprise healthcare market. The company is based in Tel Aviv, Israel and had total funding to date of $22M following the Series A. Navina is a Tel Aviv, Israel–based developer of an AI-driven platform for primary care. The company uses medically-informed AI to replace disorganized patient data with a Patient Portrait — a logical grid that enables primary care physicians to assess cases in minutes. The platform is designed to reduce missed diagnoses and enhance financial performance for providers and payers. Navina's system has already been integrated into several large, multi-specialty physician groups in the United States. The company raised $7M in seed funding and intends to use the proceeds to advance R&D of its proprietary AI and machine learning platform. It also plans to drive business development initiatives to expand utilization within physician groups and the enterprise healthcare market.